Axogen Inc (FRA:LT3)
€ 6.25 -0.25 (-3.85%) Market Cap: 285.76 Mil Enterprise Value: 333.88 Mil PE Ratio: 0 PB Ratio: 3.27 GF Score: 63/100

Q1 2022 AxoGen Inc Earnings Call Transcript

May 04, 2022 / 08:30PM GMT
Release Date Price: €7.2 (-2.04%)
Operator

Good day, ladies and gentlemen, and welcome to the AxoGen, Inc. Reports First Quarter Earnings Call. (Operator Instructions)

At this time, it is my pleasure to turn the floor over to your host, Ed Joyce. Sir, the floor is yours.

Ed Joyce
AxoGen, Inc. - Director of IR

Thank you, Dagmar, and good afternoon, everyone. Joining me on today's call is Karen Zaderej, AxoGen's Chairman, Chief Executive Officer and President; Erick DeVinney, Vice President of Peripheral Nerve Science and Clinical Innovation; and Pete Mariani, Executive Vice President and Chief Financial Officer. Karen will discuss the quarter and our outlook for the year, Erick will discuss the RECON study and top line results, and Pete will provide an analysis of our financial performance, followed by closing remarks from Karen, and a question-and-answer Session.

Today's call is being broadcast live via webcast, which is available on the Investors section of the AxoGen website. Within an hour following the end of the live call, a replay will be available on the Investor section of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot